Determinants of Parathyroid Hormone Levels During the First Year After Kidney Transplantation

Transplant Proc. 2021 Nov;53(9):2771-2774. doi: 10.1016/j.transproceed.2021.08.031. Epub 2021 Sep 25.

Abstract

Background: Spontaneous remission of secondary hyperparathyroidism after kidney transplantation requires time to occur. The aim of the present study was to investigate factors that may be related to the reduction of parathyroid hormone (PTH) after transplantation as well as the rate of its reduction.

Methods: We studied 81 kidney transplant recipients at our transplantation center between January 2014 and September 2017. The relationship of PTH values during the first year after transplant with renal function, type of kidney graft origin (deceased or living), and delayed renal graft function was examined. Moreover, we determined the correlation of the rate of PTH reduction within the first year with the value of PTH before transplant.

Results: Of the total of 81 recipients, 28 (35.1%) were women and 53 (64.8%) were men, with a mean age of 47 ± 11.87 years. At the same time, there was a decrease of PTH by 33% in the first half of the first year after transplantation and by 57% in the second. In addition, a statistically significant correlation of PTH with renal function was found (P = .001), with PTH values decreasing as the glomerular filtration rate increased. Finally, transplants from deceased donors were associated with higher values of PTH, whereas the value of PTH before transplant was positively correlated with the value after it (P = .001).

Conclusions: Secondary hyperparathyroidism, which accompanies end-stage chronic renal failure, usually resolves adequately after transplantation. The determinants of this resolution are the recipient's renal function, the kidney graft origin (deceased), and the pretransplant PTH values.

MeSH terms

  • Adult
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Hyperparathyroidism, Secondary*
  • Kidney Failure, Chronic* / surgery
  • Kidney Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Parathyroid Hormone

Substances

  • Parathyroid Hormone